Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ).
On July 24, 2025, Peter Dritschilo resigned from his roles as President, Chief Operating Officer, and Secretary of Shuttle Pharmaceuticals Holdings, Inc., effective immediately.
Spark’s Take on SHPH Stock
According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.
Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.
To see Spark’s full report on SHPH stock, click here.
More about Shuttle Pharmaceuticals Holdings, Inc.
Average Trading Volume: 292,743
Technical Sentiment Signal: Sell
Current Market Cap: $4.23M
See more insights into SHPH stock on TipRanks’ Stock Analysis page.